Discusses the impact of limited market size on epilepsy treatments and shows how an early-stage venture funds can catalyze rapid development of new therapies.

Discusses the impact of limited market size on epilepsy treatments and shows how an early-stage venture funds can catalyze rapid development of new therapies.
«Hide

from
Henry W. Chesbrough
Source: Harvard Business School
22 pages.
Release Date: 8 February 2002. Prod #: 602124-PDF-ENG
Neurotherapy Ventures: Catalyzing innovation Neurological HBR case solution